The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine

Nearly three million members are now eligible for reimbursement when prescribed with the FDA-cleared, drug-free REN wearable. The Nerivio REN wearable is effective for both preventive and acute migraine care. Closing the gap for affordable migraine care: New coverage announced for the Nerivio REN wearable giving more people access to this FDA-cleared, non-drug migraine treatment for both preventive and acute use. BRIDGEWATER, N.J. and NETANYA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Theranica, a prescr ...